GlassScriptPhysician profile
Alexander M Markov
NPI 1053806927
$2,438.53
in general payments reported to CMS, 2019-2025
31 companies · $465 in 2025
The $465 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.09 · 2022: $30.45 · 2023: $719 · 2024: $1,196 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,321 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,320.59 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $474.31 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.91 | 2022-2025 | Jardiance |
| Lilly USA, LLC | $184.25 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $172.47 | 2023-2025 | Farxiga |
| Sequel Med Tech, LLC | $159.04 | 2025 | Twiist |
| Amgen INC. | $147.99 | 2024-2025 | Evenity, Prolia, Repatha |
| Ascendis Pharma Endocrinology INC | $108.42 | 2023 | |
| Mannkind Corporation | $107.99 | 2023-2024 | Afrezza |
| Xeris Pharmaceuticals, INC. | $101.47 | 2024-2025 | Recorlev, Gvoke Hypopen, Keveyis |
| Novartis Pharmaceuticals Corporation | $87.28 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $86.97 | 2023-2025 | |
| Corcept Therapeutics | $84.75 | 2024-2025 | Korlym |
| Pfizer INC. | $69.52 | 2023-2024 | |
| Ibsa Pharma INC. | $52.70 | 2023-2024 | Tirosint, Tirosint, Licart |
| Abbott Laboratories | $42.15 | 2019-2024 | Freestyle Libre 3 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $41.61 | 2024 | Xyosted |
| Intuity Medical INC | $37.15 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Dexcom, INC. | $33.55 | 2024-2025 | Dexcom G6 Transmitter |
| Radius Health, INC. | $25.10 | 2024 | Tymlos |
| Abbvie INC. | $24.95 | 2024 | |
| Jazz Pharmaceuticals INC. | $24.56 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $22.47 | 2023 | Livalo |
| Bayer Healthcare Pharmaceuticals INC. | $20.36 | 2023 | |
| Alexion Pharmaceuticals, INC. | $17.80 | 2023 | Strensiq |
| Tris Pharma INC | $17.78 | 2024 | Dyanavel Xr |
| Tandem Diabetes Care, INC. | $17.20 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Amphastar Pharmaceuticals, INC. | $16.98 | 2024 | |
| Insulet Corporation | $16.72 | 2024 | Omnipod |
| Esperion Therapeutics, INC. | $15.97 | 2023 | Nexletol |
| Merck Sharp & Dohme LLC | $15.12 | 2024 | Verquvo |
| Beta Bionics, INC. | $11.99 | 2024 | Ilet Bionic Pancreas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Markov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.